{"id":"W2893097539","doi":"10.1111/dom.13547","title":"Health‐related quality of life in people with type 2 diabetes participating in the LEADER trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novo Nordisk","keywords":"Liraglutide; Medicine; Placebo; Quality of life (healthcare); EQ-5D; Visual analogue scale; Confidence interval; Physical therapy; Clinical trial; Type 2 diabetes; Internal medicine; Diabetes mellitus; Gerontology; Health related quality of life; Alternative medicine; Nursing; Endocrinology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003121201,0.0004668031,0.00160822,0.0001650176,0.0003280212,0.000868137,0.0003729691,0.0008505292,0.002719081],"category_scores_gemma":[0.002563005,0.0001665781,0.001325732,0.0002553621,0.0003076624,0.0006372095,0.0004961603,0.001300689,0.0004271417],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002602812,"about_ca_system_score_gemma":0.0005003668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004930287,"about_ca_topic_score_gemma":0.001037179,"domain_scores_codex":[0.998607,0.0008943019,0.00009317222,0.0001558231,0.0001368333,0.0001129783],"domain_scores_gemma":[0.9991494,0.0002081949,0.0002766206,0.00006485673,0.00009834918,0.0002025112],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7432036,0.006728979,0.1489643,0.002692497,0.006501563,0.0002024179,0.0002791459,0.0007528357,0.001976799,0.0003619622,0.006290258,0.08204565],"study_design_scores_gemma":[0.5398307,0.1761146,0.258669,0.001033965,0.009977317,0.0003658352,0.000480114,0.002103527,0.001245872,0.0009777546,0.009111376,0.00008986899],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867108,0.007489738,0.0002902588,0.000835075,0.0002230668,0.000651325,0.001053142,0.00003212405,0.00271443],"genre_scores_gemma":[0.9905401,0.002121179,0.0005928612,0.001031778,0.0004260085,0.001696612,0.002076337,0.000006830046,0.001508241],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003121201,"threshold_uncertainty_score":0.01650667,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03952394011067687,"score_gpt":0.3006571993597987,"score_spread":0.2611332592491218,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}